People · Operator
Named in public records as an officer, director or promoter · active 2012–2018 · Biotechnology, Other Health Care
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Cardiodx Inc | — | Biotechnology | Series C | $174.0M | $742.4M | 2012 |
| Dermira, Inc. | — | Other Health Care | Series C | $113.0M | $22.9M | 2014 |
Andrew L. Guggenhime at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew L. Guggenhime on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Wende Hutton | 1 | 16 |
| Brook Byers | 1 | 13 |
| Michael Goldberg | 1 | 11 |
| Patrick Enright | 1 | 10 |
| Risa Stack | 1 | 9 |
| EUGENE A. BAUER | 1 | 7 |
| Patrick G. Enright | 1 | 7 |
| James R. Tobin | 1 | 6 |
| William Ericson | 1 | 6 |
| Jake Nunn | 1 | 5 |
| Ajit Singh | 1 | 5 |
| Louis G. Lange | 1 | 4 |
| David E. Cohen | 1 | 4 |
| Jake R. Nunn | 1 | 4 |
| Arthur M. Pappas | 1 | 3 |
| Fred G. Cohen | 1 | 3 |
| Eugene Bauer | 1 | 3 |
| Brook H Byers | 1 | 3 |
| Thomas Wiggans | 1 | 3 |
| David Levison | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.